Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-25-000646
Filing Date
2025-05-13
Accepted
2025-05-13 20:49:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14052
2 e664499_ex99-a.htm EX-99.A 5291
3 e664499_ex99-b.htm EX-99.B 812
  Complete submission text file 0001193805-25-000646.txt   21777
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87833 | Film No.: 25942247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)